As of 2024-12-12, the Intrinsic Value of Amgen Inc (AMGN) is
336.91 USD. This Amgen valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 273.41 USD, the upside of Amgen Inc is
23.20%.
The range of the Intrinsic Value is 218.12 - 627.84 USD
336.91 USD
Intrinsic Value
Amgen Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
218.12 - 627.84 |
336.91 |
23.2% |
| DCF (Growth 10y) |
251.55 - 649.93 |
368.16 |
34.7% |
| DCF (EBITDA 5y) |
221.65 - 379.42 |
291.81 |
6.7% |
| DCF (EBITDA 10y) |
253.82 - 429.14 |
329.76 |
20.6% |
| Fair Value |
39.35 - 39.35 |
39.35 |
-85.61% |
| P/E |
119.30 - 264.84 |
186.88 |
-31.6% |
| EV/EBITDA |
163.86 - 294.28 |
229.53 |
-16.0% |
| EPV |
115.51 - 188.99 |
152.25 |
-44.3% |
| DDM - Stable |
60.93 - 157.83 |
109.38 |
-60.0% |
| DDM - Multi |
190.20 - 347.27 |
242.53 |
-11.3% |
Amgen Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
146,966.08 |
| Beta |
0.62 |
| Outstanding shares (mil) |
537.53 |
| Enterprise Value (mil) |
198,353.08 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.76% |
| Cost of Debt |
5.68% |
| WACC |
8.30% |